Inhibitors—Recent insights-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitors—Recent insights

Published:2020-06-30 Issue:S3 Volume:27 Page:28-36
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Pratt Kathleen P.¹,Arruda Valder R.²³^ORCID,Lacroix‐Desmazes Sébastien⁴^ORCID

Affiliation:

1. Department of Medicine Uniformed Services University of the Health Sciences Bethesda MD USA

2. The Raymond G. Perelman Center for Cellular and Molecular Therapeutics The Children's Hospital of Philadelphia Philadelphia PA USA

3. The Department of Pediatrics Perelman School of Medicine at the University of Pennsylvania Philadelphia PA USA

4. Centre de recherche des Cordeliers INSERM Sorbonne Université, Université de Paris Paris France

Funder

Institut National de la Santé et de la Recherche Médicale

Centre National de la Recherche Scientifique

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14077

Reference71 articles.

1. FEIBAR safety profile in multiple modes of clinical and home-therapy application

2. Emicizumab Prophylaxis in Hemophilia A with Inhibitors

3. Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors

4. Inhibitors in Nonsevere Hemophilia A: What Is Known and Searching for the Unknown

5. Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low‐dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor‐titer below 200 BU/mL;Pediatric Investigation;2024-06

2. A creative approach to managing a case of haemophilia A with inhibitors in a low-resource country: case report;The Journal of Haemophilia Practice;2023-01-01

3. Immune complications and their management in inherited and acquired bleeding disorders;Blood;2022-09-08

4. Hemophilia A gene therapy: current and next-generation approaches;Expert Opinion on Biological Therapy;2022-01-06

5. FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis;Drug Discovery Today;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3